| Product NDC: | 0145-0071 |
| Proprietary Name: | VELTIN |
| Non Proprietary Name: | clindamycin phosphate and tretinoin |
| Active Ingredient(s): | 10; .25 mg/g; mg/g & nbsp; clindamycin phosphate and tretinoin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0145-0071 |
| Labeler Name: | Stiefel Laboratories Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050803 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100729 |
| Package NDC: | 0145-0071-60 |
| Package Description: | 1 TUBE in 1 CARTON (0145-0071-60) > 60 g in 1 TUBE |
| NDC Code | 0145-0071-60 |
| Proprietary Name | VELTIN |
| Package Description | 1 TUBE in 1 CARTON (0145-0071-60) > 60 g in 1 TUBE |
| Product NDC | 0145-0071 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate and tretinoin |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20100729 |
| Marketing Category Name | NDA |
| Labeler Name | Stiefel Laboratories Inc |
| Substance Name | CLINDAMYCIN PHOSPHATE; TRETINOIN |
| Strength Number | 10; .25 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient],Retinoid [EPC],Retinoids [Chemical/Ingredient] |